In addition, the duration of dapagliflozin treatment was from 12 to 52 weeks, the age of T1DM patients were in the range of 41.9–55.0 years, the baseline value of HbA1c ranged from 7.40 to 8.53%, the duration of T1DM ranged from 18.98 to 30 years, and the total baseline insulin dose was in the range of 44.7–63.1 IU, which are shown in the Supplementary Data. This evidence concerns the gene INS and type 1 diabetes mellitus.